Metraipolis › archive › dc_e35baa19c485

Evidence on SGLT2 Inhibitors' Efficacy in Older and Frail Patients — Europe PMC PMID:41899142

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41899142
DOI
10.3390/jcm15062219
License (as archived)
solo-consultazione
Archived
2026-11-04T09:51:49.460Z
SHA-256 of the archived text
647c8675c8590d50a77484979329fb29aa7217fc3dee22b7795e4256665e6d96
Stable URL of this page
https://metraipolis.com/documento/dc_e35baa19c485

How to cite

Evidence on SGLT2 Inhibitors' Efficacy in Older and Frail Patients — Europe PMC PMID:41899142 — Europe PMC (en), https://europepmc.org/article/MED/41899142 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e35baa19c485 (Metraipolis archive dc_e35baa19c485, sha256 647c8675c8590d50a77484979329fb29aa7217fc3dee22b7795e4256665e6d96)
BibTeX
@misc{dce35baa19c485,
  title = {Evidence on SGLT2 Inhibitors' Efficacy in Older and Frail Patients — Europe PMC PMID:41899142},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41899142},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e35baa19c485; sha256 647c8675c8590d50a77484979329fb29aa7217fc3dee22b7795e4256665e6d96},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41899142. Agents can read the archived copy with the MCP tool read_document.